We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
China Kintor's Covid drug candidate cuts hospital, death risk in trial
Law Law Headlines News
Patients with mild to moderate symptoms participated in proxalutamide trial.